expression is induced in fasting and the diabetic state and causes insulin resistance and glucose intolerance (18) . Induction of hepatic ERRg impairs insulin signaling through diacylglycerol-mediated protein kinase e activation (19) , suggesting that ERRg transcriptional activity could be involved in insulin action to maintain glucose homeostasis. Recently, our laboratory reported that insulin-dependent phosphorylation of ERRg alters its transcriptional activity to suppress hepatic gluconeogenesis in the fed state (20) .
PGC-1a is a transcriptional coactivator involved in hepatic glucose metabolism. Fasting induces hepatic PGC-1a expression that directly interacts with transcription factors, including hepatocyte nuclear factor 4a, FOXO1, and glucocorticoid receptor, to increase the expression of gluconeogenic genes (21, 22) . PGC-1a overexpression leads to increased expression of G6Pase and PEPCK, key enzymes in the hepatic gluconeogenesis. Conversely, knockdown or knockout of PGC-1a results in lower blood glucose levels as a result of reduced gluconeogenesis.
As insulin-dependent posttranslational modification regulates the transcriptional activity of ERRg in the fed state, in this study, we investigated whether fasting-dependent activation of the transcriptional activity of ERRg involves O-GlcNAcylation. We demonstrate that the fasting condition triggers O-GlcNAcylation of ERRg that results in protein stabilization. O-GlcNAcylation of ERRg by OGT decreases its ubiquitination and cooperatively upregulates gluconeogenesis. In contrast, the fed condition decreases O-GlcNAcylation of ERRg, resulting in ubiquitin-mediated protein degradation. Overall, our study describes how O-GlcNAcylation modulates gluconeogenesis via ERRg.
RESEARCH DESIGN AND METHODS

Animal Experiments
Male 8-week-old C57BL/6J mice, maintained at the Korea Research Institute of Bioscience and Biotechnology (KRIBB) were fed either a high-fat diet (HFD) (D12492; Research Diets, New Brunswick, NJ) or a normal chow diet for 12 weeks. At the end of 12 weeks, mice were sacrificed, and liver tissue was used for identification of O-GlcNAcylation of ERRg. ob/ob and db/db mice (7-12 weeks old; Charles River Laboratories) were maintained at KRIBB in an animal facility with ad libitum access to water and a standard laboratory diet. Liver tissue was used for identification of O-GlcNAcylation of ERRg. Male 7-week-old C57BL/6J mice (The Jackson Laboratory, Bar Harbor, ME) were obtained from Ochang Branch Institute, KRIBB. After 2 weeks, adenoviruses (Ad-green fluorescent protein [GFP], Ad-wild-type [wt] ERRg, and Ad-S317A+S319A ERRg; 5.9 3 10 9 plaque-forming units/mouse) were delivered by tail-vein injection into mice. Glucose tolerance test was performed at day 5 after a tail-vein injection of adenoviruses. Briefly, mice fasted 16 h were injected intraperitoneally with 1 g/kg glucose, and blood glucose was measured in tail-vein blood using a blood glucose meter and test trips (Accu-Chek Aviva meter system; Roche Diagnostics, Indianapolis, IN). All mice were acclimatized to a 12-h light/dark cycle at 22 6 2°C with free access to food and water in a specific pathogen-free facility. All animal experiments were approved and performed by the Institutional Animal Care and Use Committee of KRIBB.
Glucose Output Assay
Glucose production from primary mouse hepatocytes was measured using a colorimetric glucose oxidase assay kit according to the manufacturer's protocol. Briefly, after the experimental time period as indicated, the cells were washed three times with PBS. Then the cells were incubated for 3 h at 37°C, 5% CO 2 , in glucose production buffer (glucose-free DMEM [pH 7.4] , containing 20 mmol/L sodium lactate, 1 mmol/L sodium pyruvate, and 15 mmol/L HEPES, without phenol red), and the glucose assays were performed.
Glucagon Assay
Blood glucagon levels were measured using the mouse glucagon EIA kit (Ray Biotech) following the manufacturer's protocol.
Cell Culture and Reagents
Primary hepatocytes were isolated from C57BL/6J mice (male, 20-30 g) by collagenase perfusion (23) and seeded with Medium 199 (Cellgro). After 3-6 h of attachment, cells were infected with the indicated adenoviruses for overexpression or treated with various chemicals as indicated. HEK 293T and AML12 cells were maintained as described previously (24) . Transient transfection was performed using Lipofectamine 2000 (Invitrogen) or SuperFect (Qiagen, Hilden, Germany) according to the manufacturers' instructions. b-N-Acetyl-D-glucosamine (GlcN), 6-diazo-5-oxo-L-norleucine (DON), glucagon, insulin, cycloheximide, ANTI-FLAG M2 affinity gel, glucose oxidase assay kit, and streptozotocin (STZ) were purchased from Sigma-Aldrich. MG-132 protease inhibitors were purchased from Calbiochem. Express Protein Labeling Mix [ 35 S] (NEG072002MC) was purchased from PerkinElmer. The Mouse Glucagon EIA kit (EIAM-GLU) was purchased from Ray Biotech. Antibodies were purchased as follows: O-GlcNAc from Covance, a-tubulin from Abfrontier, ERRg from Perseus Proteomix, OGT from Abcam, FLAG, Anti-FLAG M2, and hemagglutinin (HA) from Cell Signaling Technology, and G6Pase, Mdm2, ubiquitin, Gal4, PGC-1a, and PEPCK from Santa Cruz Biotechnology.
Plasmid and Adenovirus Vector Constructs
Expression vectors for HA-ERRg, FLAG-ERRg, HA-PGC1a, and Sft4-luc containing three copies of the ERRg binding site were described previously (25) . HA-ERRa was described previously (26) . FLAG-human OGT was constructed by inserting the full PCR fragment of the open reading frame into the Not1/Sal1 sites of the p3XFLAG-CMV-7.1 vector. FLAG-human O-GlcNAcase (OGA) was constructed by inserting the full PCR fragment of the open reading frame into the Bgl2/Sal1 sites of the pFLAG-CMV-7.1 vector. FLAG-mutant ERRg's (S317A, S319A, and S317A+S319A) were constructed using wild-type ERRg as a template by the Quick Change Lightning Site-Directed Mutagenesis kit from Agilent Technologies. Gal4-DNA binding domain (DBD) and Gal4-tk-Luc were described previously (27) . Briefly, Gal4-ERRg-ligand-binding domain (LBD) is a fusion protein consisting of the Gal4-DBD (amino acids 1-147) and ERRg-LBD (amino acids 189-458). This fusion protein activates transcription of a reporter construct (Gal4-tkluc) containing five GAL4 binding sites (upstream activator sequence) upstream of the firefly luciferase gene in the pGL2-promoter. Gal4-DBD-S317A ERRg, Gal4-DBD-S319A ERRg, and Gal4-DBD-S317A+S319A ERRg were constructed using Gal4-DBD-wild-type ERRg as a template by the Quick Change Lightning Site-Directed Mutagenesis kit from Agilent Technologies. wtPEPCK-luc, and ERRg response element (ERRE) mutant PEPCK-luc were described previously (28) . Adenoviruses expressing unspecific short hairpin (sh)RNA, shERRg, control GFP, and ERRg were described previously (28) . Ad-OGT encoding the human OGT gene, adenovirus OGA (Ad-OGA) encoding the human OGA gene, and adenovirus S317A+S319A ERRg (Ad-S317A+S319A ERRg) were generated with the pAd-easy system as described previously (29) . All viruses were purified by using CsCl gradient protocol.
Hepatic FLAG-ERRg Complex Purification and Mapping of O-GlcNAc Site Using Mass Spectrometry
Overexpressed wild-type FLAG-ERRg proteins from mouse liver were purified using FLAG-M2 agarose and subjected to SDS-PAGE. Purified protein was digested with trypsin (Promega, Madison, WI) (25 ng/mL) for 16 h at 37°C. After in-gel digestion, tryptic peptides were separated by online reversed-phase chromatography using a Thermo Scientific Eazy nano LC II autosampler (Thermo Scientific) with a reversed-phase peptide trap EASY-Column (100-mm inner diameter, 2-cm length) and a reversed-phase analytical EASY-Column (75-mm inner diameter, 10-cm length, 3-mm particle size; both from Thermo Scientific). Electrospray ionization was performed using a 30-mm (inside diameter) nano-bore stainless steel online emitter (Thermo Scientific) and a voltage set at 2.6 V, at a flow rate of 300 nL/min. The chromatography system was coupled on-line with an LTQ Velos Orbitrap mass spectrometer (Thermo Scientific). Protein identification was accomplished using the Proteome Discoverer v1.3 database search engine (Thermo Scientific), and searches were performed against IPI.Humanv3.87 FASTA database or ERRg FASTA database. A fragment mass tolerance of 1.2 Da, peptide mass tolerance of 25 ppm, and maximum missed cleavage of 2 were set.
Real-Time Quantitative RT-PCR Analysis
Total RNA was isolated using TRIzol reagent (Invitrogen), cDNA was synthesized using a reverse transcriptase kit (Intron Biotechnology), and real-time quantitative RT-PCR (qPCR) was performed with the SYBR green PCR kit (Enzynomics). The amount of mRNA for each gene was normalized to that of actin mRNA.
Chromatin Immunoprecipitation Assay
Nuclear isolation of primary hepatocytes and cross-linking of protein to DNA were performed as described previously (28) . After sonication, soluble chromatin was subjected to immunoprecipitation using anti-ERRg antibody. DNA was recovered by phenol/chloroform extraction and analyzed by PCR using primers against relevant promoters. Primer sequences were mouse PEPCK1 promoter forward, 59-CTAGCCAGCTTTGCCTGACT-39 and reverse, 59-GGGTCCCCACGACCTTCCAA-39.
Western Blot Analysis
Whole-cell extracts were prepared using radioimmunoprecipitation assay (RIPA) buffer (50 mmol/L Tris [pH 7.5], 150 mmol/L NaCl, 1% Nonidet P-40, and 5 mmol EDTA). Proteins from whole-cell lysates were separated by 10% SDS-PAGE and then transferred to nitrocellulose membranes. The membranes were probed with different antibodies. Immunoreactive proteins were visualized using an Amersham Biosciences ECL kit (GE Healthcare) according to the manufacturer's instructions.
In Vivo Imaging
C57BL/6J mice were infected with respective viruses via tail-vein injections. Four days postinjection, mice were fasted for 16 h and imaged using an IVIS Lumina II imaging system (Caliper Life Sciences, Hopkinton, MA) as described previously (28) .
Confocal Microscopy
At 24 h after transfection, the cells were fixed with 2% formaldehyde, immunostained, and subjected to observation by confocal microscopy using a laser-scanning confocal microscope (Olympus, Lake Success, NY).
Pulse-Chase Experiment
AML12 cells were transfected with FLAG-wt ERRg, FLAG-S317A ERRg, FLAG-S319A ERRg, and FLAG-S317A+S319A ERRg and incubated in methionine and cystine-free medium for 2 h. Translabel mixture (PerkinElmer) containing 35 S-methionine was added for 30 min, and then cells were cultured in normal medium up to 3 h. FLAGERRg was immunoprecipitated with M2 antibody in RIPA buffer, and radioactive FLAG-ERRg was detected by autoradiography.
Statistical Analyses
All values are expressed as means 6 SEM. The significance between mean values was evaluated by two-tailed Student t test.
RESULTS
ERRg Is Modified by O-GlcNAc
ERRg is a key positive regulator of hepatic gluconeogenesis (28) . ERRg phosphorylation by protein kinase B/Akt also contributes to insulin-mediated inhibition of hepatic gluconeogenesis (20) . Many factors that regulate hepatic gluconeogenesis are O-GlcNAcylated in various conditions (7, 30, 31 (Fig. 1A) . Consistent with a rise in ERRg protein levels, GlcN treatment significantly reduced ERRg ubiquitination levels and increased ERRg transcriptional activity ( Supplementary Fig. 1A and B). Glucose (Glc) flux through HBP regulates O-GlcNAcylation (1). Therefore, to determine whether glucose could directly affect O-GlcNAcylation of ERRg, mouse primary hepatocytes (MPH) were treated with 5 and 25 mmol/L glucose. High glucose significantly increased O-GlcNAcylation of ERRg along with ERRg protein levels (Fig. 1B) . This was further confirmed when OGT cotransfection markedly enhanced O-GlcNAcylation of ERRg (Fig. 1C) . Because ERRa and ERRg are both associated with hepatic glucose metabolism, we also examined whether OGT overexpression could lead to ERRa O-GlcNAcylation. Unlike ERRg, O-GlcNAcylation was not detected for ERRa (Fig. 1D) .
O-GlcNAcylation is linked with protein stability (30) (31) (32) (33) . From our results ( Fig. 1A and B), we speculated that O-GlcNAcylation could stabilize ERRg by decreasing protein degradation. To test this, HEK 293T cells were cotransfected with ERRg and OGA or OGT expression vectors followed by MG-132 treatment to inhibit proteasomemediated protein degradation. ERRg ubiquitination levels were significantly raised and O-GlcNAcylation levels were decreased in presence of OGA, whereas OGT had an entirely opposite effect, suggesting that OGT triggers ERRg O-GlcNAcylation that inhibits ERRg ubiquitination and stabilizes it (Fig. 1E) . Next, to examine the functional implications of O-GlcNAcylation, reporter gene assay with transient transfection was carried out in the 293T cell line. ERRg significantly enhanced the Sft4-luc reporter activity, which was further augmented in presence of OGT. OGA had an inverse effect to that of OGT and significantly reduced ERRg transcriptional activity. However, ERRa could not markedly activate the reporter gene even in presence of OGT (Fig. 1F) . Activation of the Gal4-tk-luc reporter gene by Gal4-ERRg-LBD was significantly augmented by OGT, whereas OGA significantly repressed it, indicating that O-GlcNAcylation of ERRg might occur in its LBD (Fig. 1G ). Overall, these results suggest that ERRg is subject to O-GlcNAcylation, which in turn increases protein stability by decreasing ubiquitin mediated protein degradation and also enhances ERRg transcriptional activity.
Glucagon Increases O-GlcNAcylation of ERRg
Hepatic ERRg expression is increased by fasting-dependent activation of the CREB-CRTC2 pathway (18, 28) . Hence, we sought to determine whether fasting-dependent increase in ERRg expression is associated with O-GlcNAcylation. Fasting significantly enhanced O-GlcNAcylation of ERRg compared with the fed state. This stands in contrast to ERRg ubiquitination levels that were higher in the fed condition than the fasting condition, suggesting that O-GlcNAcylation mediates ERRg stability in the fasting condition ( Fig. 2A) . To confirm that O-GlcNAcylation mediates ERRg stability in the fasting condition, we overexpressed OGA in this condition. Overexpression of OGA significantly reduced O-GlcNAcylation of ERRg and simultaneously increased ubiquitination of ERRg, resulting in lowering of ERRg abundance, unambiguously establishing that ERRg stability is governed by O-GlcNAcylation in the fasting condition (Fig. 2B) . Increased protein stability is associated with decreased interaction between protein and E3 ubiquitin-ligases such as Mdm2 (32) . We observed that fasting increased OGT-ERRg interactions in a time-dependent manner, resulting in enhanced O-GlcNAcylation and reduced Mdm2-ERRg interactions in mice (Fig. 2C) . The binding of OGT and ERRg was reduced, but the levels of ERRg O-GlcNAcylation were still intensified after 3 h of fasting (Fig. 2C) . To clarify this, we tested whether the interactions between ERRg and OGT or OGA might be dynamically altered during the fasting period. The interaction between ERRg and OGT increased in a fasting time manner, reaching a peak between 3 and 6 h and then declining, whereas the interaction between ERRg and OGA decreased in a fasting time manner ( Supplementary  Fig. 1C ), suggesting that in the fed state, OGA interacts with ERRg and destabilizes it, whereas in the fasting condition OGT interacts with ERRg and stabilizes it. Interestingly, protein levels of both OGT and OGA were increased in the fasting ( Supplementary Fig. 1C ), which was supported by elevated OGT and OGA mRNA levels in fasting (Supplementary Fig. 1D ). In spite of low circulating glucose, fasting promoted O-GlcNAcylation of ERRg. Hence, we speculate that glucagon could be more important than blood glucose for O-GlcNAcylation of ERRg during fasting. To test this, we measured blood glucose and glucagon levels in a fasting time-course experiment ( Supplementary Fig. 1E and F). Blood glucose levels in fasting mice decreased from 0 to 12 h, whereas serum glucagon levels steadily increased from 0 h, reaching a peak at 6 h, followed by a decrease at 12 h, though it remained significantly higher at 12 h than at 0 h. ERRg O-GlcNAcylation levels gradually increased from 0 h, reaching a peak at 6 h and then remaining almost the same until 12 h, suggesting that circulating glucagon levels are more important than circulating glucose levels for O-GlcNAcylation of ERRg during fasting.
Glucagon increases hepatic ERRg transcriptional activity during fasting (28) . Thus, we sought to ascertain whether glucagon increases ERRg transcriptional activity by affecting O-GlcNAcylation. Glucagon treatment significantly increased ERRg O-GlcNAcylation levels, resulting in higher protein stability through reduced ERRg ubiquitination (Fig. 2D) . As both high glucose (Fig. 1B) and glucagon (Fig. 2D) induced O-GlcNAcylation, we tested which is more important for O-GlcNAcylation of ERRg. Both high levels of glucose and glucagon increased ERRg O-GlcNAcylation levels and total protein levels. They have a cumulative effect when applied together ( Supplementary Fig. 1G ), but unlike glucagon, glucose did not increase ERRg mRNA levels ( Supplementary  Fig. 1H ). The notion that O-GlcNAcylation mediates the effect of glucagon on ERRg protein stability was further corroborated when overexpression of OGA significantly reduced both O-GlcNAcylation and protein levels of ERRg (Fig. 2E) . Insulin induced by feeding suppresses ERRg transcriptional activity as well as gene expression (20, 28) . Thus, we speculate that insulin may inhibit O-GlcNAcylation of ERRg, leading to decreased protein stability. As we expected, glucagon-induced ERRg O-GlcNAcylation was significantly suppressed by insulin treatment in AML12 cells. ERRg ubiquitination was markedly enhanced in presence of insulin compared with glucagon treatment, resulting in lower protein stability (Fig.  2F) . Taken together, these results indicate that fasting increases O-GlcNAcylation of ERRg, leading to protein stability, whereas feeding acts reciprocally to degrade ERRg by suppressing its O-GlcNAcylation.
ERRg Is Modified by O-GlcNAc at S317 and S319
In order to identify the O-GlcNAc site of ERRg, we infected mice with Ad-FLAG-ERRg and extracted the ERRg protein from liver tissue through immunoprecipitation ( Fig. 3A and B) . The mass spectrometry results show that S317 and S319 of ERRg are O-GlcNAcylated (Supplementary Figs. 2 and 3) . The primary structure of ERRg revealed that S317 and S319 were present in the LBD of ERRg (Fig. 3C) , which was consistent with the previous result that suggested O-GlcNAcylation site is in the LBD (Fig. 1G) . However, only S317 was conserved in ERRa, ERRb, and ERRg (Fig. 3C) . The three-dimensional structure of ERRg-LBD provides a comprehensive view of the O-GlcNAcylation site. The two O-GlcNAcylated serine residues are located at the end of helix5 of the reported ERRg-LBD structures, which is locally stabilized with helix 6, helix 7, and a couple of strands. Although S319 is completely exposed to the solvent-accessible surface, S317 is partially hidden (Fig. 3D) . To verify the specific O-GlcNAcylation sites indicated by mass analysis, we constructed three site-specific point mutant cDNAs of ERRg, S317A ERRg, S319A ERRg, and S317A+S319A ERRg. The single mutants (S317A ERRg and S319A ERRg) showed less O-GlcNAcylation compared with wild-type ERRg, whereas the double mutant (S317A+S319A ERRg) showed complete absence of an O-GlcNAc signal in the presence of GlcN (Fig. 3E) . Interestingly, even though the single mutants showed higher O-GlcNAcylation than the double mutant, all three mutants were highly ubiquitinated compared with wild-type in presence of GlcN, unambiguously suggesting that O-GlcNAcylation of both S317 and S319 is required for ERRg protein stability (Fig.  3E) . Consistent with these findings, we noticed that all three mutants showed significantly lower stability compared with wild-type in a pulse-chase experiment, demonstrating the importance of O-GlcNAcylation in ERRg protein stability (Fig. 3F) . This was further confirmed when all three mutants showed significantly reduced protein levels in the presence of cycloheximide, a protein synthesis inhibitor (Supplementary Fig. 4A ). Next, reporter gene assay reveled that unlike wild-type, the mutant ERRg had no significant transcriptional activity, suggesting that O-GlcNAcylation is required for ERRg transcriptional activity as well (Fig. 3G) . All three mutants were unable to bind to the PEPCK promoter revealing why they had no transcriptional activity (Fig. 3H) . Collectively, these results illustrate that O-GlcNAcylation stabilizes ERRg and increases its transcriptional activity. A: C57BL/6 mice (n = 5) were fasted for 6 h and refed for 2 h, followed by liver tissue isolation. Immunoprecipitation (IP) with ERRg antibody and immunoblot with O-GlcNAc, ubiquitin (Ub), ERRg, and a-tubulin antibodies were performed. All of the samples were combined for Western blot analyses. B: Ad-green fluorescent protein (GFP) or Ad-OGA was administered via tail-vein injection into C57BL/6 mice (n = 6). At day 6 after injection, mice were fasted for 6 h and sacrificed. Liver tissue from mice was homogenized for immunoprecipitation with ERRg antibody and immunoblot with O-GlcNAc, Ub, ERRg, and a-tubulin antibodies. All of the samples were combined for Western blot analyses. C: Liver tissue from C57BL/6 mice (n = 5), fasted for different time points as indicated, was homogenized for immunoprecipitation with ERRg antibody and immunoblot with O-GlcNAc, OGT, Mdm2, ERRg, and a-tubulin antibodies. All of the samples were combined for Western blot analyses. D: AML12 cells were transfected with FLAGERRg. At 24 h posttransfection, cells were incubated with vehicle or glucagon (100 nmol/L) for different time points as indicated. Immunoprecipitation with FLAG antibody and immunoblot with O-GlcNAc, Ub, FLAG, and a-tubulin antibodies were performed. E: AML12 cells were transfected with FLAG-ERRg. At 24 h posttransfection, cells were infected with Ad-GFP or Ad-OGA as indicated. At 24 h postinfection, cells were incubated with glucagon (100 nmol/L) for 6 h followed by immunoprecipitation with FLAG antibody and immunoblot with O-GlcNAc, Ub, FLAG, and a-tubulin antibodies were performed. F: AML12 cells were transfected with FLAG-ERRg. At 24 h posttransfection, cells were incubated with glucagon (100 nmol/L) for 6 h or glucagon (100 nmol/L) for 6 h followed by insulin (100 nmol/L) for 6 h. Immunoprecipitation with FLAG antibody and immunoblot with O-GlcNAc, OGT, Ub, FLAG, and a-tubulin antibodies were performed. hr, hour.
Figure 3-ERRg is modified by O-GlcNAcylation at S317 and S319.
A: C57BL/6 mice (n = 5) were injected via tail veins with adenoviral vector expressing FLAG-ERRg. Six days later, mice were fasted for 6 h, and liver extracts were prepared. The FLAG-ERRg was purified using anti-FLAG M2 agarose. B: Proteins were separated using SDS-PAGE and stained by colloidal Coomassie Blue. C: Schematic diagram of ERRg structure (amino acids 1-458). ERRg consists of N-terminal domain, DBD, hinge domain, LBD, and COOH-terminal domain. ERRg is O-GlcNAcylated at S317 and S319. The amino acid sequences of ERR family members ERRa, ERRb, and ERRg are given below. D: Two serine residues of ERRg-LBD. Twelve LBD structures (Protein Data Bank identification numbers 2ewp, 2gpp, 2gp7, and 2p7z) were superimposed, which showed root mean SD values of <0.4 Å for all the aligned residues. ERRg-AF-2 domain is represented as an orange color surface and ERRg-LBD as a gray-colored surface with two serine residues in space-filling models in the left and bottom right panels. In the top right panel, the superimposed ERRg-LBD structures are displayed with ribbons and differentiated by colors; two serine residues are drawn as stick models. E: AML12 cells were transfected with plasmids encoding FLAG-wt ERRg, FLAG-S317A ERRg, FLAG-S319A ERRg, and FLAG-S317A+S319A ERRg. At 24 h after transfection, cells were treated with GlcN (10 mmol/L) for 6 h and MG-132 (10 mmol/L) for 6 h followed by immunoprecipitation (IP) with FLAG antibody and immunoblot with O-GlcNAc, ubiquitin (Ub), FLAG, and a-tubulin antibodies. F: AML12 cells transfected with FLAG-wt ERRg, FLAG-S317A ERRg, FLAG-S319A ERRg, and FLAG-S317A+S319A ERRg were metabolically labeled for 30 min followed by chase for the indicated times. FLAG-ERRg was immunoprecipitated with M2 antibody and detected by autoradiography. G: ERRg-dependent activation of the Sft4-luc. Transient transfection was performed in HEK 293T cells with the indicated plasmid DNAs. H: ChIP assay showing the occupancy of wild-type ERRg, S317A ERRg, S319A ERRg, and S317A+S319A ERRg on ERRE1 of PEPCK1 promoter from DMSO and GlcN-treated AML12 cells. Error bars show 6 SEM. ***P < 0.0005 using Student t test.
O-GlcNAcylation Affects ERRg-PGC-1a Interaction but Not ERRg Cellular Localization
Increase in transcriptional activity of transcription factors in response to O-GlcNAcylation was previously linked to their nuclear transport (7, 34) . Because the O-GlcNAcylation mutant ERRg had practically no transcriptional activity compared with wild-type ( Fig. 3G and H) , we speculate that the O-GlcNAcylation mutant may not translocate into the nucleus. Unexpectedly, the S317A+S319A ERRg was located in the nucleus, indicating that subcellular localization of ERRg was not governed by O-GlcNAcylation (Fig. 4A) . Transcriptional coactivator PGC-1a interacts with ERRg and is critical for ERRg transcriptional activity (28) . Hence, we examined whether PGC-1a could interact with S317A+S319A ERRg. In AML12 cells, GlcN treatment significantly augmented O-GlcNAcylation of ERRg as well as ERRg-PGC-1a interaction, whereas inhibiting HBP by treating with DON, an inhibitor of GFAT, the rate-limiting enzyme of HBP, significantly reduced O-GlcNAcylation of ERRg as well as ERRg-PGC-1a interaction. We could not detect any interaction between S317A+S319A ERRg and PGC-1a, supporting the idea that the HBP mediates ERRg-PGC-1a interaction (Fig. 4B) . We also observed that GlcN treatment increased PGC-1a protein levels (Fig.  4B ), but not mRNA levels ( Supplementary Fig. 4B ). The rise in PGC-1a protein levels could be because O-GlcNAcylation also stabilizes PGC-1a protein (30) . Next, STZ treatment, an inhibitor of OGA and promoter of O-GlcNAcylation (7, 35) , significantly augmented PGC-1a-ERRg interaction, demonstrating that OGA inhibition enhances O-GlcNAcylation of ERRg that results in substantial increase in PGC-1a-ERRg interaction (Fig. 4C) . Along with ERRg (FLAG), PGC-1a (HA) protein levels were also elevated in response to STZ treatment (Fig. 4C) , which is consistent with Fig. 4B , in which GlcN treatment elevated PGC-1a protein levels. Next, we performed in vitro interaction study between PGC-1a and Gal4 construct containing either wild-type or S317A+S319A ERRg-LBD as the LBD contains the O-GlcNAcylation site (Fig. 3C ). Similar to Gal4-wild-type ERRg-LBD, Gal4-S317A+S319A ERRg-LBD protein was as stable as the wild-type one, but we could not detect any interaction between PGC-1a and Gal4-S317A+S319A ERRg-LBD, suggesting that O-GlcNAcylation in the LBD regulates ERRg-PGC-1a interaction (Fig. 4D) . Similar to the double mutant, the two single mutants also could not interact with PGC-1a ( Supplementary Fig. 4C ). Gal4-tk-Luc reporter gene assay revealed that Gal4-S317A+S319A ERRg-LBD was incapable of activating the reporter gene in the presence of PGC-1a (Fig. 4E) . Moreover, Gal4-S317A+S319A ERRg-LBD was also unable to activate the reporter gene even in presence of GlcN or OGT (Supplementary Fig. 4D ). Taken together, these results demonstrate that O-GlcNAcylation regulates ERRg-PGC-1a interaction critical to ERRg transcriptional activity.
O-GlcNAcylation Regulates ERRg-Mediated Gluconeogenic Gene Expression
HBP induces gluconeogenic enzymes gene expression through O-GlcNAcylation (7), (30) . ERRg is a key positive regulator of gluconeogenic enzymes gene expression (28), (18) . Our previous results described that ERRg was O-GlcNAcylated through HBP (Figs. 1A, 4B and C) . Therefore, to determine the contribution of O-GlcNAcylated ERRg in HBP-induced gluconeogenesis in MPH, we knocked down endogenous ERRg. ERRg knockdown markedly reduced GlcN-induced PEPCK and G6Pase protein levels (Fig. 5A) . OGT overexpression leads to induction of gluconeogenesis and OGT knockdown improves glucose homeostasis in diabetic mice (7, 30) . OGT overexpression significantly increased PEPCK and G6Pase mRNA levels, and this increase in mRNA levels was greatly suppressed by ERRg knockdown in MPH (Fig.  5B, from left, first and second panel) . In line with PEPCK and G6Pase mRNA levels results, glucose production was also significantly reduced in response to ERRg knockdown (Fig. 5B, rightmost panel) . Effectiveness of OGT overexpression was confirmed by Western blot analyses (Supplementary Fig. 4E) . Next, to examine the effect of glucose or GlcN on gluconeogenic gene promoter activity, we used wild-type and ERRE mutant PEPCK promoter, which is devoid of ERRg binding site. Exposure to glucose or GlcN increased wild-type promoter activity, but this increase was greatly reduced with the ERRE mutant PEPCK promoter (Fig. 5C) . In a parallel approach, 293T cells were transfected with wild-type PEPCK promoter along with wild-type and S317A+S319A ERRg. Wild-type ERRg considerably increased the promoter activity that was further augmented in presence of OGT, whereas OGA coexpression greatly impaired ERRg effect. At the same time, S317A+S319A ERRg could not greatly activate the promoter (Fig. 5D) . Next, chromatin immunoprecipitation (ChIP) assay was performed in MPH to monitor the effect of HBP inhibition on ERRg recruitment to the endogenous PEPCK gene promoter. Under basal conditions, ERRg occupied the PEPCK promoter. However, GlcN treatment significantly augmented ERRg occupancy on the PEPCK promoter, whereas HBP inhibition by DON treatment markedly diminished the occupancy. We also observed a similar binding pattern of PGC-1a (Fig. 5E) . Together, these results demonstrate that O-GlcNAcylation by HBP governs gluconeogenic activity of ERRg.
ERRg O-GlcNAcylation Is Required for Hepatic Gluconeogenesis
Diabetic conditions induce ERRg gene expression and promote gluconeogenesis (18) . Hence, we speculated that ERRg could be O-GlcNAcylated under diabetic conditions. As we expected, O-GlcNAcylation of ERRg was greatly increased in HFD-fed, ob/ob, and db/db mice ( Fig. 6A and B) . Previously, it was reported that diabetic conditions promoted OGT gene expression (7) . We also noticed a significant increase in OGT mRNA levels in HFD-induced diabetic mouse, although OGA mRNA levels were also elevated ( Supplementary Fig. 4F ). Overexpression of ERRg promotes hepatic gluconeogenesis and elevates blood glucose levels (18, 28) . Therefore, we compared the effect of wild-type and S317A+S319A ERRg overexpression in mouse liver. In accordance with previous results, glucose excursion during intraperitoneal glucose tolerance test was significantly higher in Ad-wild-type ERRg-injected mice compared with control mice, but Ad-S317A+S319A ERRg-injected mice showed normal blood glucose levels (Fig. 6C) . Fasting blood glucose levels and PEPCK and G6Pase mRNA levels were significantly higher for Adwild-type ERRg infection compared with Ad-S317A+S319A ERRg (Fig. 6D) . Effectiveness of ERRg overexpression was confirmed by Western blot analyses (Supplementary Fig.  4G ). Next, to negate the effect of O-GlcNAcylation, we overexpressed OGA in mouse liver. Disrupting O-GlcNAcylation of ERRg in mice infected with Ad-wild-type ERRg through overexpression of hepatic OGA by Ad-OGA greatly lowered the gluconeogenic profile (Fig. 6E) . Effectiveness of ERRg overexpression was confirmed by Western blot analyses ( Supplementary Fig. 4H ). Finally, based on the previous result ( Fig. 6C and D) , we performed in vivo imaging analysis to verify the effect of O-GlcNAcylation of ERRg on hepatic gluconeogenesis at the transcriptional levels. Adwild-type ERRg-dependent induction of PEPCK promoter activity was significantly reduced in mice injected with Ad-S317A+S319A ERRg (Fig. 6F) . Overall, these results suggest that O-GlcNAcylation is prerequisite for ERRg to trigger hepatic gluconeogenesis.
DISCUSSION
Several transcription factors promote gluconeogenesis in the fasted state and type 2 diabetes. We hypothesize that in the fasting and diabetic states, gluconeogenesis generates fructose-6-phosphate, which is used by HBP to O-GlcNAcylate transcription factors and coactivators to further promote gluconeogenesis. In the current study, we show that ERRg is stabilized by O-GlcNAcylation in the fasted and diabetic states to promote gluconeogenic gene induction. Hence, we suggest a positive feed-forward loop in which glucose entry into the HBP promotes gluconeogenesis in the fasting and diabetic conditions in the liver.
Glucagon-insulin crosstalk regulates ERRg protein stability and transcriptional activity (20, 28) . In this study, we investigated whether ERRg protein stability and transcriptional activity is influenced by O-GlcNAcylation. In fact, glucagon stabilized ERRg by promoting its O-GlcNAcylation (Fig.  2D-F) . O-GlcNAcylation can increase protein stability and transcriptional activity by inhibiting ubiquitination or promoting deubiquitination (30) (31) (32) (33) . It can also reduce protein stability and transcriptional activity by increasing ubiquitination (36, 37) . However, we observed that O-GlcNAcylation stabilized ERRg protein by inhibiting its ubiquitination (Fig. 2D-F) . Our results clearly demonstrated that incremental O-GlcNAcylation-mediated reduction in ubiquitination was a result of greater inhibition of the interaction between ERRg and E3 ubiquitin ligase Mdm2 that resulted in increased protein stability (Fig. 2C) . Phosphorylation of GFAT1 by cAMPdependent protein kinase blocks its enzyme activity (38) , whereas phosphorylation of GFAT2 by cAMP-dependent protein kinase increases its enzyme activity (39) . Our observation that glucagon robustly enhances O-GlcNAcylation of ERRg and insulin inhibits it (Fig. 2F) could be due to GFAT2 activation. O-GlcNAcylation can affect transcription factors by modifying key residues involved in their interaction with coactivators (40) . It can also induce important conformational changes within transcription factors, which might have a direct impact on their activity, as demonstrated for the estrogen receptor (41) . Threedimensional structural features of ERRg also suggest that O-GlcNAcylation may trigger a conformational change of ERRg-LBD that contains the AF-2 domain (Fig. 3D) . This probable conformational change may be crucial for inhibition of ubiquitination and ERRg-PGC-1a interaction. Perhaps, S317A ERRg and S319A ERRg, in spite of being partially O-GlcNAcylated, were heavily ubiquitinated (Fig.  3E ) and unable to interact with PGC-1a ( Supplementary  Fig. 4C ). The two single mutants may not attain the desired conformational change required to inhibit ubiquitination and interact with coactivator PGC-1a due to incomplete O-GlcNAcylation. Further investigation is required to confirm whether O-GlcNAcylation influences ERRg-LBD structure. Previously, Yang et al. (42) reported that the transcripts of ERRg followed a cyclic pattern in its diurnal rhythmicity in the liver. ERRg transcripts reach maximum levels in the liver during the daytime. The observed result of O-GlcNAcylation-mediated stability of ERRg may have been influenced by the diurnal rhythmicity in the liver.
O-GlcNAcylation takes place in response to high glucose or insulin (31, 43, 44) . PGC-1a and CRTC2 undergo O-GlcNAcylation in hyperglycemic and hyperinsulinemic diabetic mouse (7, 30) . Interestingly, low-glucose conditions also promote O-GlcNAcylation (7, 9, 30) . Glucose deprivation induces protein O-GlcNAcylation and OGT expression as well (45) . All of these reports suggest that both high-and low-glucose conditions promote O-GlcNAcylation in vitro and in vivo. Glucose in the form of fructose-6-phosphate is used by hexosamine biosynthetic pathway to O-GlcNAcylate proteins under different conditions. In the fed conditions, high circulating glucose could be converted to fructose-6-phosphate and used in O-GlcNAcylation. Although the circulating glucose Figure 6 -ERRg O-GlcNAcylation required for hepatic gluconeogenesis. O-GlcNAcylation of ERRg in diabetic conditions. ERRg was immunoprecipitated (IP) with ERRg antibody followed by immunoblot with O-GlcNAc, ERRg, PEPCK, and a-tubulin antibodies from liver tissue of C57BL/6 mice (n = 3) fed with normal chow diet (NCD) and HFD (A) from wild-type, ob/ob, and db/db mice (n = 3) (B). C: Ad-GFP, Ad-wt ERRg, or Ad-S317A+S319A ERRg were administered via tail-vein injection into C57BL/6 mice (n = 5). Glucose tolerance test at day 5 after injection. Glucose was measured at the indicated times after 1 g/kg intraperitoneal glucose injection. D, left panel: 4-h fasting blood glucose levels in C57BL/6 mice (n = 5) at day 6 after Ad-GFP, Ad-wt ERRg, or Ad-S317A+S319A ERRg injection. D, middle and right panels: qPCR analyses of total RNA isolated from liver at day 7 after injection. E, left panel: 4-h fasting blood glucose levels in C57BL/6 mice (n = 5) at dayconcentration is high in the diabetic condition, the diabetic condition differs from the fed condition in that the activity of glucokinase, which converts glucose to glucose-6-phosphate, is low in the liver (46) , (47, 48) . Therefore, circulating glucose is less readily converted to fructose-6-phosphate in the diabetic condition. In the diabetic conditions hepatic gluconeogenesis is significantly upregulated (49) , producing fructose-6-phosphate, which could be used in O-GlcNAcylation. Furthermore, in low circulating glucose (fasting) conditions, glycogenolysis and gluconeogenesis are both called into play to maintain blood glucose levels. During early fasting, glycogenolysis, stimulated by glucagon, produces glucose-6-phosphate, which is in equilibrium with fructose-6-phosphate (50) . Therefore, glycogenolysis, especially during early fasting, is surely a major source of fructose-6-phosphate. During short-term fasting, glucagon also triggers the initial induction of hepatic gluconeogenesis through activation of CREB-CRTC2 (7). In prolonged fasting, PGC-1a, FOXO1, and ERRg promote hepatic gluconeogenesis (28, 30, 51) . During that initial induction period (short-term fasting), hepatic glycogenolysis and gluconeogenesis produce fructose-6-phosphate, which might be used to O-GlcNAcylate ERRg to further promote gluconeogenesis during prolonged fasting. We observed that blood glucose levels were decreased during fasting in a timedependent manner, whereas serum glucagon levels and ERRg O-GlcNAcylation levels were steadily increased (Supplementary Fig. 1E and F) , indicating that circulating glucagon levels are more important than circulating glucose levels for O-GlcNAcylation of ERRg in fasting. Moreover, OGT mRNA levels were significantly enhanced in response to fasting, even though OGA mRNA levels were also enhanced, but it was less significant compared with OGT (Supplementary Fig. 1D ). Enhanced OGT mRNA levels could also be responsible for fasting-dependent O-GlcNAcylation of ERRg.
Conserved ERRE on the PEPCK promoter is required for the transcription of that gene in response to fasting and diabetes-mediated gluconeogenesis (18, 28) ; hence, we explored the role of ERRg in HBP mediated gluconeogenesis. Loss of endogenous ERRg in primary hepatocytes led to a significant decrease in HBP-induced gluconeogenic profile (Fig. 5) , implying the importance of O-GlcNAcylation of ERRg in the context of gluconeogenesis. Diabetic conditions promote O-GlcNAcylation mediated gluconeogenesis in the diabetic mice (7, 30) . As a matter of fact, ERRg was highly O-GlcNAcylated in diabetic mice ( Fig. 6A and B) . Hepatic overexpression of wild-type ERRg caused glucose intolerance with hyperglycemia, whereas O-GlcNAcylation mutant ERRg overexpression showed glucose tolerance with euglycemia in mice ( Fig. 6C and D) . O-GlcNAcylation was blocked by using either OGT or GFAT inhibitor or by enzymatically modulating OGA or OGT expression to investigate the effect of their inhibition on glycemia in diabetic mice. The OGT inhibitor alloxan was used in many studies (52) (53) (54) , but it has wide off-target effects and general cellular toxicity (55) . Another OGT inhibitor, Ac 4 -5S-GlcNAc, was used in wide range of studies (56-58), but it affects other glycosyltransferase and impairs N-glycosylation and extracellular glycan synthesis in cultured cell lines (59) . Moreover, the enzymatic approach modulating OGA or OGT expression was successfully used to restore glucose homeostasis. Overexpression of hepatic OGA or knockdown of hepatic OGT inhibited aberrant gluconeogenesis and significantly improved glycemic conditions in diabetic mice (7, 30, 31) . We observed that disruption of O-GlcNAcylation by hepatic OGA overexpression reduced gluconeogenic profile in normal mice expressing Ad-ERRg (Fig. 6E) , unambiguously illustrating that O-GlcNAcylation is prerequisite for gluconeogenic function of ERRg.
We conclude that the fasting and diabetic conditions promote O-GlcNAcylation of ERRg. O-GlcNAcylation is imperative for ERRg protein stability and enhances gluconeogenic activity of ERRg. The fed state, however, reduces O-GlcNAcylation of ERRg, resulting in ubiquitin-mediated degradation of ERRg (Fig. 6G) . Our results indicate a vital role for O-GlcNAcylation of ERRg in maintaining normal glucose levels during fasting and also in mediating the elevated blood glucose levels in type 2 diabetes. Hence, pharmacological inhibition of O-GlcNAcylation-mediated hyperactivation of ERRg might provide a pathway for preventing hyperglycemia and treating type 2 diabetes.
